Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma.
about
Selective use of vandetanib in the treatment of thyroid cancer.PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.The RET C611Y mutation causes MEN 2A and associated cutaneous
P2860
Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Skewed mutational spectrum of ...... h medullary thyroid carcinoma.
@en
type
label
Skewed mutational spectrum of ...... h medullary thyroid carcinoma.
@en
prefLabel
Skewed mutational spectrum of ...... h medullary thyroid carcinoma.
@en
P2093
P2860
P1433
P1476
Skewed mutational spectrum of ...... h medullary thyroid carcinoma.
@en
P2093
Golnoush Dehbashi Behbahani
Marjan Zarif Yeganeh
Mehdi Hedayati
Samaneh Farashi
Sara Sheikholeslami
P2860
P2888
P304
P356
10.1007/S13277-015-3179-7
P577
2015-02-20T00:00:00Z
P6179
1035895610